Correlation Between Prakash Steelage and Beta Drugs

Can any of the company-specific risk be diversified away by investing in both Prakash Steelage and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prakash Steelage and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Prakash Steelage Limited and Beta Drugs, you can compare the effects of market volatilities on Prakash Steelage and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prakash Steelage with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prakash Steelage and Beta Drugs.

Diversification Opportunities for Prakash Steelage and Beta Drugs

-0.19

Correlation Coefficient

Prakash Steelage  Beta Drugs

Good diversification

The 3 months correlation between Prakash and Beta is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Prakash Steelage Limited and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Prakash Steelage is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prakash Steelage Limited are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Prakash Steelage i.e., Prakash Steelage and Beta Drugs go up and down completely randomly.

Pair Corralation between Prakash Steelage and Beta Drugs

Assuming the 90 days trading horizon Prakash Steelage Limited is expected to under-perform the Beta Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Prakash Steelage Limited is 1.16 times less risky than Beta Drugs. The stock trades about -0.03 of its potential returns per unit of risk. The Beta Drugs is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  169,995  in Beta Drugs on September 23, 2024 and sell it today you would earn a total of  36,010  from holding Beta Drugs or generate 21.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Prakash Steelage Limited  vs.  Beta Drugs

Prakash Steelage

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Prakash Steelage Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Prakash Steelage is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Beta Drugs

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Prakash Steelage and Beta Drugs

The main advantage of trading using opposite Prakash Steelage and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prakash Steelage position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.

The idea behind Prakash Steelage Limited and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.